Fall 2017

We want to know what you think about CURE® magazine. Address your comments to [email protected]. If you prefer that your comment not be published, please indicate.

In the fall issue of CURE, several feature stories have a commonality involving key principles of humanity that are often compromised for those living with cancer.

IN THIS ISSUE OF CURE® magazine, we celebrate a first. In March, the immunotherapy Bavencio (avelumab) became the first treatment approved by the FDA specifically to treat the rare skin disease Merkel cell carcinoma, a neuroendocrine cancer of the skin.

An oncology nurse learns what it’s like to have cancer — and uses the experience to improve the way patients are treated.

An antibody–drug conjugate is being tested in patients with platinum-resistant ovarian cancer.

When does a patient become a survivor of cancer? Some believe it’s at the moment of diagnosis, but others disagree.

Cancer during pregnancy challenges the entire family.

Women diagnosed with cancer while pregnant can undergo treatment that is tailored to protect their babies’ safety.

Hypnosis can reduce side effects and stress for patients with cancer, and even substitute for anesthesia during some surgeries.

Programs that help improve physical appearance during cancer treatment may do even more to lift patients’ spirits.

An immunotherapy finally gives doctors an approved weapon to fight Merkel cell carcinoma, a rare and still mysterious skin cancer.

Author Shannon Benish knows what really makes a difference during a cancer journey. She saw her daughter, Erin, through hers, which began with a diagnosis at age 11 and led to remission and life as a healthy teenager.

When treated for cancer, young patients don’t always get the information they need from doctors.

Socioeconomic status, race and other disparities among patients can affect cancer treatments and outcomes. Researchers are working to change that.